Skip to main content
Equibles

Archer Investment Corp

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1803804 Carmel, IN
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$78,270
+$13,640 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#528
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Archer Investment Corp holds $770,226 across 19 Biotechnology names. HALO ranks #3 (10.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KRYS
Krystal Biotech, Inc.
 830 $308,486
2 GALT
Galectin Therapeutics Inc
 17,401 $80,740
3 HALO
Halozyme Therapeutics, Inc.
This page 		1,000 $78,270
4 PVLA
Palvella Therapeutics, Inc.
 449 $68,616
5 IBRX
ImmunityBio, Inc.
 5,872 $51,409
6 IONS
Ionis Pharmaceuticals Inc
 600 $47,574
7 ARWR
Arrowhead Pharmaceuticals, Inc.
 500 $40,755
8 MRNA
Moderna, Inc.
 520 $36,415

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $78,270 1,000
2026-03-31 $64,630 1,000
2025-12-31 $67,300 1,000
2025-09-30 $73,340 1,000
2025-06-30 $52,020 1,000
2025-03-31 $63,810 1,000
2024-12-31 $47,810 1,000
2024-09-30 $57,240 1,000
2024-06-30 $52,360 1,000
2024-03-31 $40,680 1,000
2023-12-31 $36,960 1,000
2023-09-30 $38,200 1,000
2023-06-30 $36,070 1,000
2023-03-31 $38,190 1,000
2022-12-31 $56,900 1,000
2022-09-30 $39,540 1,000
2022-06-30 $44,000 1,000
2022-03-31 $39,880 1,000
2021-12-31 $40,210 1,000
2021-09-30 $40,680 1,000
2021-06-30 $45,410 1,000
2021-03-31 $41,690 1,000
2020-12-31 $42,710 1,000
2020-09-30 $26,280 1,000
2020-06-30 $26,810 1,000
2020-03-31 $17,990 1,000